All Posts By

Smartkarma Daily Briefs

Daily Brief Health Care: Pacific Smiles, Indegene Limited, M3 Inc, Siloam International Hospitals, AFT Pharmaceuticals, Intuitive Surgical and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Pacific Smiles (PSQ AU): A Brace Of Offers
  • Indegene Limited Pre-IPO: Subscribe on Profitable Niche Business Model and Attractive Valuation
  • M3 4Q Results: Earnings Miss and Further Slowdown Seems Unavoidable
  • Siloam International Hospitals (SILO IJ) – Raising Clinical Acuity
  • AFT Pharmaceuticals – Expanded R&D pipeline to fuel LT growth
  • Intuitive Sugrical: How Long Will The Growing Procedure Volume Last & What Are The Major Challenges Ahead? – Major Drivers


Pacific Smiles (PSQ AU): A Brace Of Offers

By David Blennerhassett

  • On the 18th December 2023, Pacific Smiles (PSQ AU), an operator of dental centers, announced and rejected a A$1.40/share non-binding proposal from Genesis Capital. Genesis subsequently increased its stake to 19.90%.
  • Genesis then bumped its NBIO to A$1.75/share on the 19 March and was granted due diligence on a non-exclusive basis. PSQ said it would support the revised terms if firmed. 
  • PSQ has now entered a Scheme with National Dental Care at A$1.90/share. The Offer also requires FIRB signing-off. But the proposal is a non-starter if Genesis rejects terms. 

Indegene Limited Pre-IPO: Subscribe on Profitable Niche Business Model and Attractive Valuation

By Tina Banerjee

  • Indegene Limited (1864095D IN) has set IPO price band at INR430–452 per share. The IPO consists of fresh issue as well as OFS by existing shareholders.
  • Considering FY24 annualized post-IPO EPS of INR13.48, Indegene seeks a P/E valuation of 31.9–33.5x.
  • Considering niche business focus, proven execution capability, marquee clientele, long-standing client relationship, life science focus, and comprehensive offering, Indegene’s valuation seems quite attractive.

M3 4Q Results: Earnings Miss and Further Slowdown Seems Unavoidable

By Shifara Samsudeen, ACMA, CGMA

  • M3 Inc (2413 JP) reported 4Q and Full-year FY03/2024 results. Earnings missed both guidance as well as consensus due to slowdown in Medical Platform and Overseas businesses.
  • Medical Platform’s earnings declined further in 4Q with spending cuts by pharma companies, and it seems that the segment’s earnings will further decline going forward.
  • M3’s share price is down 18% YTD, and we do not see many catalysts to drive a rally in the company’s share price.

Siloam International Hospitals (SILO IJ) – Raising Clinical Acuity

By Angus Mackintosh

  • Siloam International Hospitals booked a solid set of 1Q2024 results, with sustained QoQ improvements in revenues, EBITDA, and profits, stripping out a one-off write-down for hospitals under development. 
  • The company also saw strong improvements in operational metrics including inpatient and outpatient days, with especially strong performance in March due to a dengue epidemic, which also diluted patient intensity. 
  • Siloam International Hospitals saw continuing strength in more complex treatments, as it focused on raising clinical acuity in areas such as transplants and cardiology. Valuations remain attractive relative to peers.

AFT Pharmaceuticals – Expanded R&D pipeline to fuel LT growth

By Edison Investment Research

While AFT continues to gain commercial traction from Maxigesic/ Combogesic IV sales in the US (launched by partner Hikma in Q1 CY24) and anticipates the launch of Crystaderm in China, a strong R&D pipeline is central to AFT’s long-term growth ambitions. AFT recently announced the seventh addition to its R&D portfolio, a non-invasive topical alternative treatment for keloid and hypertrophic scarring, addressing the limited treatment algorithm for keloid scars (raised, thickened scars). This development collaboration is with Massey Ventures and the Gillies McIndoe Research Institute, and continues AFT’s initial collaboration with these parties from 2022, for the treatment of strawberry birthmarks.


Intuitive Sugrical: How Long Will The Growing Procedure Volume Last & What Are The Major Challenges Ahead? – Major Drivers

By Baptista Research

  • Intuitive Surgical delivered a healthy first quarter performance with strong procedure growth and solid capital placements.
  • However, the company also faced some regional challenges during the quarter.
  • Core measures of the company’s operations remained strong, as seen in its robust procedure growth and solid capital placements.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Consumer: L’Occitane, Kfc Holdings Japan, SHEIN, Toyo Suisan Kaisha, Prosus NV, Fuyao Glass Industry Group, Mitsubishi Motors, JD.com Inc (ADR) and more

By | Consumer, Daily Briefs

In today’s briefing:

  • L’Occitane (973 HK): Conditional VGO at HK$34
  • Carlyle Reportedly To Buy KFC Japan (9873) From MitCorp (8058) – Deal Likely Imminent
  • KFC Holdings Japan (9873 JP): Carlyle Edging Towards a Tender Offer
  • L’Occitane (973 HK): Geiger’s $34/Share Offer
  • SHEIN IPO: The Biggest IPO in 2024 in London?
  • Toyo Suisan: Activist Advocates For Legacy Divestiture & More Capital for Global Expansion
  • NPN X PRX Discount Update Post Tencent Early Game Release News Flow
  • Fuyao Glass (3606 HK):  Global Champion Benefiting From Structural Uptrend
  • Quiddity JPX-Nikkei 400 Rebal 2024: End-Apr 2024 Estimates
  • International Automobile Analysis


L’Occitane (973 HK): Conditional VGO at HK$34

By Arun George

  • L’Occitane (973 HK) disclosed a conditional voluntary offer from Reinold Geiger at HK$34.00, a 15.3% premium to the last close and a 30.8% premium to the undisturbed price (5 February).
  • The minimum acceptance condition is that the offeror holds at least 90% of the shares held by disinterested shareholders, which enables the offeror to exercise compulsory acquisition rights.
  • Irrevocable and letters of support to accept represent 37.96% of disinterested shares. An attractive offer (representing an all-time high) should facilitate the offer being declared unconditional.

Carlyle Reportedly To Buy KFC Japan (9873) From MitCorp (8058) – Deal Likely Imminent

By Travis Lundy

  • On 28 Feb, the Nikkei reported (an article I missed) Mitsubishi Corp (8058 JP) would seek to unload its 35% stake in Kfc Holdings Japan (9873 JP) 
  • The stock popped, then continued to rise further. After the close Friday, the Nikkei reported MitCorp was close to a deal with Carlyle. A deal is apparently expected imminently.
  • I expect this could be a “Split Price Deal” (like Hitachi Transport and Pasona).

KFC Holdings Japan (9873 JP): Carlyle Edging Towards a Tender Offer

By Arun George

  • The Nikkei reports that Carlyle is in the final stages of buying Mitsubishi Corp (8058 JP)’s 35% stake in Kfc Holdings Japan (9873 JP), which will result in a tender offer. 
  • The structure will likely be similar to the KDDI Corp (9433 JP)/ Lawson Inc (2651 JP) tender, where MitCorp provides an irrevocable NOT to accept but vote for share consolidation.
  • The shares have been up 33.6% since Nikkei flagged the sale on 28 February. KFC Japan will trade in line with peers’ multiples at a JPY5,700 offer.  

L’Occitane (973 HK): Geiger’s $34/Share Offer

By David Blennerhassett

  • After nearly six years of conjecture, rumour – plus the key shareholder (holding 72.63% of shares out) contemplating a takeover – we finally have an Offer for L’Occitane (973 HK).
  • The price? $34/share, a 30.77% premium to undisturbed, and a figure a shade below the  HK$35/share flagged by Reuters last August deemed “false and without basis“. The price is final. 
  • This takeover is a Voluntary General Offer. The key condition is securing 90% of disinterested shareholders holding 27.36%. 9.6% of that number have provided irrevocable undertakings or letters of support.  

SHEIN IPO: The Biggest IPO in 2024 in London?

By Douglas Kim

  • Although Shein has yet to formally announce the listing destination, there is a growing anticipation that the listing venue could be London, rather than New York. 
  • It has been reported that the company has more than doubled its net profit to more than US$2 billion in 2023. 
  • The company is currently seeking a corporate value of nearly US$70 billion to US$90 billion in the Shein IPO which would be one of the biggest IPOs globally in 2024. 

Toyo Suisan: Activist Advocates For Legacy Divestiture & More Capital for Global Expansion

By Oshadhi Kumarasiri

  • Japanese instant noodle manufacturer Toyo Suisan Kaisha (2875 JP) has become the newest target for activist investors in Japan.
  • Nihon Global Growth Partners Management, Inc argues that Toyo Suisan’s investments are overly concentrated in its legacy businesses, despite these ventures yielding low returns.
  • Therefore, they are recommending that Toyo Suisan exit its legacy businesses, increase the payout ratio to 40%, and use some of its excess cash for a share buyback of ¥20bn.

NPN X PRX Discount Update Post Tencent Early Game Release News Flow

By Charlotte van Tiddens, CFA

  • Last week Monday, Tencent confirmed the early release of Dungeon and Fighter Mobile, a highly anticipated mobile adaptation of the computer game developed by Nexon.
  • The game is expected to be released in China on the 21st of May following positive test results.
  • Tencent was the 11th best performing constituent in the HSTECH index for the week (out of 30), returning 14.7%. The index ended the week up 13.4%.

Fuyao Glass (3606 HK):  Global Champion Benefiting From Structural Uptrend

By Steve Zhou, CFA

  • Fuyao Glass Industry Group (3606 HK) is the largest auto glass producer in the world, with an estimated 40% market share globally, and a dominant 65% market share in China.
  • The investment case for Fuyao include:  ASP increase from product mix upgrade; increasing sales volume due to more auto glasses needed per car; and improving margins.
  • The company has production bases in China with annual production volume of around 32.5 million units, and in US with annual production volume of around 5.5 million units.

Quiddity JPX-Nikkei 400 Rebal 2024: End-Apr 2024 Estimates

By Janaghan Jeyakumar, CFA

  • JPX-Nikkei 400 is composed of common stocks listed on the Tokyo Stock Exchange. It is a free-float-adjusted market-value-weighted (capped) index composed of 400 constituents.
  • A periodic review is conducted by the Index providers, the JPX Group and Nikkei Inc, in August every year. We look at the rankings of the potential ADDs/DELs every month.
  • Below is a look at potential ADDs/DELs for the JPX-Nikkei 400 index rebal event to come in August 2024 based on trading data as of end-April 2024.

International Automobile Analysis

By Douglas Busch

  • Spanning the globe for current best-in-breed auto players shows diverging action.
  • New pair suggestion: Long Tesla/Short Rivian. Bottom could be in on TSLA
  • Updated JD.com general status from last week’s China/Japan Note encouraging.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Financials: Bombay Stock Exchange, Hang Seng Index, BFI Finance Indonesia, Bitcoin, Greentown China, Marsh & Mclennan, Princess Private Equity Holdin and more

By | Daily Briefs, Financials

In today’s briefing:

  • BSE – A Regulatory Accident?
  • EQD | HSI Closing April Up Changes Our Forecast!
  • BFI Finance Indonesia (BFIN IJ) – Slower Recovery in Process
  • Crypto Crisp: Stripe Returns to Crypto
  • Morning Views Asia: China Hongqiao, Greentown China, Medco Energi, Yankuang Energy Group
  • Marsh & McLennan Companies: How Will The Increased Automation & Efficiency In Operations Impact Its Bottom-Line In 2024 & 2025? – Major Drivers
  • Princess Private Equity Holding – Introducing a well-defined buyback policy


BSE – A Regulatory Accident?

By Sudarshan Bhandari

  • SEBI has asked BSE to pay regulatory fees on options trading based on notional turnover instead of premium turnover
  • The impact of this would 10-20% on earnings in short term
  • The bigger question lies ahead what BSE will do to offset the impact and grow its market share in derivative trading

EQD | HSI Closing April Up Changes Our Forecast!

By Nico Rosti

  • If the Hang Seng Index (HSI INDEX) closes the month of April up (i.e. above 16541.42), our previous forecast will change (read the insight below for the detailed analysis).
  • The index performed an impressive bounce from the support levels (16050) we indicated in our previous insight, it is very overbought (WEEKLY model) and may close April up.
  • A continuation of the WEEKLY uptrend is in doubt, this week, while the MONTHLY situation is more complex.

BFI Finance Indonesia (BFIN IJ) – Slower Recovery in Process

By Angus Mackintosh

  • BFI Finance Indonesia (BFIN IJ) booked a solid set of 1Q2024 numbers with improved QoQ bookings, although with some concerns over challenging market conditions slowing the recovery.
  • The NPF ratio saw an ongoing improvement, although the cost of capital increased due to higher write-offs from last year’s bookings. Revenue declined due to a shift to lower-risk products. 
  • The outlook for BFIN in 2H2024 looks more positive, with the company shifting back to higher-return products and with lower expected credit costs. Valuations are appealing on 1.5x PBV.

Crypto Crisp: Stripe Returns to Crypto

By Mads Eberhardt

  • It is no surprise that we have maintained a bullish stance in crypto over the past month, given the uptick in US dollar liquidity and the easing tensions between Israel and Iran.
  • Despite these factors, the market adopted a predominantly pessimistic view, highlighted by a negative futures funding rate.
  • This suggested to us that the market was misaligned with the outside environment.

Morning Views Asia: China Hongqiao, Greentown China, Medco Energi, Yankuang Energy Group

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Marsh & McLennan Companies: How Will The Increased Automation & Efficiency In Operations Impact Its Bottom-Line In 2024 & 2025? – Major Drivers

By Baptista Research

  • Based on the latest Q1 2024 financial results of Marsh & McLennan Companies Inc., there are several key highlights presenting a neutral standpoint of the company’s performance.
  • Positive aspects include strong underlying revenue growth of 9% and an upswing of 11% in adjusted operating income compared to the prior year.
  • The company’s adjusted operating margin expanded by 80 basis points from Q1 2023 and completed $300 million of share repurchases within the quarter.

Princess Private Equity Holding – Introducing a well-defined buyback policy

By Edison Investment Research

Princess Private Equity Holding’s (PEY’s) 12-month NAV total return (TR) to end-February 2024 was a modest 0.6% amid low exit activity across private equity (PE) markets. That said, if the pick-up in global M&A volumes witnessed earlier in 2024 continues, it should support PEY’s exit activity. This in turn would translate into improved returns if PEY delivers sizeable uplifts to previous carrying values upon exits, as it has done historically. In this context, we note that PEY has a good pipeline of mature investments that are potentially ripe for sale. PEY’s shares now trade at a 24% discount to NAV versus a 10-year average of 18%.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: Azure Minerals, Jumbo Interactive, Carly Holdings, Venture Minerals and more

By | Australia, Daily Briefs

In today’s briefing:

  • Merger Arb Mondays (29 Apr) – Azure, Silver Lake, Roland DG, CF Logistics, China TCM, Hollysys
  • Jumbo Interactive Ltd (JIN) – Sunday, Jan 28, 2024
  • Carly Holdings – Growth continues apace
  • Venture Minerals Ltd – Jupiter REE discovery expands the portfolio



Jumbo Interactive Ltd (JIN) – Sunday, Jan 28, 2024

By Value Investors Club

Key points

  • Jumbo Interactive Ltd (ASX: JIN) operates in the online lottery industry in Australia, with a 20% market share and offering digital Australian lottery tickets through its mobile app and website.
  • The company, founded in 1995 by CEO Mike Veverka, is highly cash generative and has a favorable duopolistic market structure, positioning it for potential stock value growth and expansion as more customers shift to online channels.
  • JIN is viewed as a defensive investment option with strong margins and cash generation potential, particularly through its SaaS/Managed Services offering, making it an appealing choice for investors looking for long-term growth.

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Carly Holdings – Growth continues apace

By Research as a Service (RaaS)

  • Carly Holdings Limited (ASX:CL8) operates a vehicle subscription service that is a shorter-term alternative to lease, loan or outright purchase of a vehicle.
  • Average subscription period is five+ months vs. three+ years for more traditional options.
  • The subscription includes insurance, registration and maintenance.

Venture Minerals Ltd – Jupiter REE discovery expands the portfolio

By Research as a Service (RaaS)

  • Venture Minerals Limited (ASX:VMS) is an ASX-listed critical minerals explorer with a focus on rare earth elements (REE), precious metals and tin-tungsten deposits in Western Australia and Tasmania.
  • The company has recently announced significant drilling assay results from its Jupiter prospect within the Brothers rare earths element project in WA which potentially positions VMS with one of the largest clay-hosted REE prospects in Australia.
  • VMS is also undertaking a feasibility study on underground mining at its Mount Lindsay tin-tungsten project in Tasmania and says it has appointed advisers, Argonaut, to undertake a strategic review of its nearby Riley iron ore mine.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thailand: Berli Jucker and more

By | Daily Briefs, Thailand

In today’s briefing:

  • SET50 Index Rebalance Preview: Market Consultation & More Changes in June


SET50 Index Rebalance Preview: Market Consultation & More Changes in June

By Brian Freitas

  • The SET has run a market consultation on relaxing liquidity thresholds for inclusion of stocks in the Stock Exchange of Thailand SET 50 Index (SET50 INDEX) universe.
  • The consultation is the result of an increase in Average Daily Trading Values and lower turnover ratios, especially for large cap stocks.
  • Berli Jucker (BJC TB) is now a potential index inclusion in June and that could result in four constituent changes at the next rebalance.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: HD Hyundai Marine Solution , Connectwave and more

By | Daily Briefs, South Korea

In today’s briefing:

  • HD Hyundai Marine Solution (443060 KS) IPO: No Passive Buying Near-Term
  • MBK’s ConnectWave Tender Offer: Details & Trading Angles
  • Connect Wave: Tender Offer of 30% of Shares by MBK Partners


HD Hyundai Marine Solution (443060 KS) IPO: No Passive Buying Near-Term

By Brian Freitas

  • HD Hyundai Marine Solution (443060 KS) is looking to raise KRW 742bn (US$540m) in its IPO, valuing the company at KRW 3,707bn (US$2.69bn). Listing is expected to be in early-May.
  • Competition for the shares has been fierce with institutional investors indicating demand for 201x the number of shares on offer at prices higher than the top end of the range.
  • Barring a doubling of the stock price, the earliest that the stock will be added to major indices is December 2024. So, no passive buying in the short-term.

MBK’s ConnectWave Tender Offer: Details & Trading Angles

By Sanghyun Park

  • MBK Partners will launch a tender offer for ConnectWave from today to May 24th. The target volume is 16.6M shares (40% of SO) at ₩18,000 per share, a 15.6% premium.
  • MBK commits to acquiring all tendered shares, regardless of subscription rates, in order to expedite the delisting process. So, there is no cancellation or allocation risk.
  • ConnectWave’s retail investor base, with high entry prices, may hinder reaching 70% of the target volume. Absence of risks suggests considering buy positions for potential secondary tender offer.

Connect Wave: Tender Offer of 30% of Shares by MBK Partners

By Douglas Kim

  • After the market close on 26 April, it was reported that MBK Partners has launched a tender offer of a 29.61% stake of Connectwave (119860 KS).
  • The tender offer price is 18,000 won, which is 15.6% higher than the closing price (15,570 won) of the company on 26 April.
  • The tender offer period is from 29 April to 24 May. The amount of the tender offer is about 300 billion won. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Hesai Group, Technology Select Sector SPDR, Tapestry Inc, Matterport and more

By | Daily Briefs, United States

In today’s briefing:

  • Hesai Group: Time To Cover Shorts As The Stock Found A Bottom and Delisting Risk Is Real
  • Time to Tiptoe Back Into Big Tech?
  • Tapestry Inc (TPR) – Sunday, Jan 28, 2024
  • Mapping New Territory


Hesai Group: Time To Cover Shorts As The Stock Found A Bottom and Delisting Risk Is Real

By Andrei Zakharov

  • Hesai Group, one of the global leaders in the LiDAR and perception solutions market, completed its IPO in February 2023 and listed ADSs on the Nasdaq Global Select Market.
  • The stock peaked at $30+ during the first trading day and fell ~67% over the following 8 months as selling pressure intensified and investor sentiment worsened.
  • The stock has taken another leg down following U.S. DoD’s decision to include Hesai Group in 1260H list of Chinese military-linked companies. Hesai believes this inclusion is unjust and meritless.

Time to Tiptoe Back Into Big Tech?

By Cam Hui

  • Big Tech has been lagging the market since February and the relative performance reset is nearing an end. The overall stock market is undergoing a bottoming process.
  • Investment-Oriented accounts should be accumulating positions at these levels, but should be prepared for some near-term choppiness.
  • Tactically, we are inclined to overweight value over growth stocks for short-term performance.

Tapestry Inc (TPR) – Sunday, Jan 28, 2024

By Value Investors Club

  • Decline in TPR’s stock price after acquisition announcement
  • Author believes acquisition will benefit Tapestry Inc financially and strategically
  • Author sees dip in stock price as buying opportunity and remains bullish on TPR’s long-term prospects

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Mapping New Territory

By subSPAC

  • The last week of SPACs was packed with activity including buyouts, amendments, and terminations.
  • A digital mapping firm gets a boost with an acquisition by a Real Estate firm, and a Rare Earth mining-focused firm rejects a buyout from a SPAC.
  • Also, a SPAC lowers the valuation of a deal with a biotech firm, and a UK-based blank-cheque firm terminates a deal with an engineering business. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Japan: Sumitomo Chemical, Kokusai Electric and more

By | Daily Briefs, Japan

In today’s briefing:

  • Sumitomo Chemical (4005): Potential Posterchild of Japan’s Resurgence
  • ECM Weekly (29th Apr 2024) – IDEA, Kokusai, J&T, Krafton, Horizon, Oceana, ChaPanda, 99 Speed, Afcon


Sumitomo Chemical (4005): Potential Posterchild of Japan’s Resurgence

By Michael Allen

  • Sumitomo Chemicals aims to transform from a cyclical company with low market share in declining markets into a focused entity with high market share in secular growth markets.
  • We estimate that the stock’s fair value is about 140% above the current price.
  • Results meeting on April 30 should confirm that company is on track in returning to positive cash flow and selling off core assets. 

ECM Weekly (29th Apr 2024) – IDEA, Kokusai, J&T, Krafton, Horizon, Oceana, ChaPanda, 99 Speed, Afcon

By Sumeet Singh


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Maruti Suzuki India, NIFTY Index and more

By | Daily Briefs, India

In today’s briefing:

  • India: Potential Free Float Changes & Passive Flows in May
  • EQD / NSE Volatility Update / 22-Apr-24 to 26-Apr-24


India: Potential Free Float Changes & Passive Flows in May

By Brian Freitas

  • Companies in India have disclosed their shareholding pattern as of end-March in April. There are companies with significant float changes from end-September and/or end-December.
  • The changes in free float could be reflected in domestic and global indices over the next few weeks and months resulting in action from passive trackers.
  • Depending on the date that the shareholding was published, there could be 14 stocks with passive inflows from global trackers while 7 could see passive outflows in May.

EQD / NSE Volatility Update / 22-Apr-24 to 26-Apr-24

By Sankalp Singh

  • SEBI extends cross-margining discounts to correlated assets with different maturities – Dispersion trading & vol arb strategies to benefit. 
  • In spite of upcoming tier-1 event risks the vol surface has flattened  dramatically. Current IV levels are supportive of a continued “High & Down” vol state.
  • Curve steepening seen in Nifty50 IVs. Unusual kinked-shaped in BankNifty term structure has normalized – vol curve now has a uniform orientation.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Tencent, Gan & Lee Pharmaceuticals, China Education Group, Air China Ltd (H), China Vanke , Hygeia Healthcare Group and more

By | China, Daily Briefs

In today’s briefing:

  • Tencent/Netease: Game Approval Rotate to Netease in April
  • China Healthcare Weekly (Apr.28)-TCM Formula Granule Outlook, Reduce CAR-T’s Price, Gan & Lee Pharma
  • China Education Group (839 HK): On Balance, Worth a Bet Now
  • Air China (753 HK): Steering Back to the Right Lane
  • Morning Views Asia: China Vanke , Road King Infrastructure
  • Hygeia Healthcare Group (6078.HK) – High Growth in 2024 Is Not Guaranteed


Tencent/Netease: Game Approval Rotate to Netease in April

By Ke Yan, CFA, FRM

  • China announced game approval for the April batch. The number of games approved remained at a higher level than 2023.
  • The pace of China game approval appears to have accelerated to the same level as pre-tightening, though the number of approvals appears to be slower than March.
  • While Tencent scored zero, Netease got approval for one game.

China Healthcare Weekly (Apr.28)-TCM Formula Granule Outlook, Reduce CAR-T’s Price, Gan & Lee Pharma

By Xinyao (Criss) Wang

  • The performance of most TCM formula granule enterprises showed slow growth or even decline due to VBP in 2023. Although VBP will continue, it also brings opportunities for related companies. 
  • Customized production, expensive upstream raw materials/production equipment, complex supply chain systems, etc. are all major reasons for the high prices of CAR-T therapy, but we see hope for changes.
  • Gan & Lee Pharmaceuticals (603087 CH)’s core insulin business will continue to have decent growth based on positive VBP renewal results. It’s expected that in 2024, performance would further rebound.

China Education Group (839 HK): On Balance, Worth a Bet Now

By Osbert Tang, CFA

  • China Education Group (839 HK) has turned more attractive after a valuation retreat and the return of reported and adjusted net profit to a positive trend in its 1H24 result.
  • Increase in the proportion of undergraduate studies, a better subject specialisation mix, higher accommodation revenue, and a rise in international education will drive unit student revenue.
  • More capacity upgrades will allow for a steady increase in student enrollment. Management expects adjusted EBITDA margin to stay stable in the next few years.

Air China (753 HK): Steering Back to the Right Lane

By Osbert Tang, CFA

  • Losses at Air China Ltd (H) (753 HK) narrowed by 42.8% YoY to Rmb1.67bn in 1Q24. If not for the exchange losses, it will be reduced to below Rmb1bn.
  • Higher jet fuel prices have dragged result despite record 1Q revenue. However, an 8.3pp YoY margin expansion and a 4% decline in unit costs indicated profitability is climbing. 
  • Valuations are too depressed as the share price is still lacklustre but quarterly losses and gross margin have already trimmed from the troughs of Rmb10.5bn and -98%, respectively.

Morning Views Asia: China Vanke , Road King Infrastructure

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Hygeia Healthcare Group (6078.HK) – High Growth in 2024 Is Not Guaranteed

By Xinyao (Criss) Wang

  • According to Hygeia’s management, the 25% growth in previous guidance for 2024 would be exceeded. 24H1 would maintain a growth rate of 40+%, and the growth in 24H2 would accelerate.
  • However, progress of some projects is slower than expected, so a growth rate of 25%+ in performance forecast seems aggressive.After all, downward adjustment of performance guidance again is very uncomfortable.
  • P/E of 30-40 is reasonable range in short term. So, Hygeia is undervalued.In long term, revenue growth could fall to 15-20% because the contribution of M&A to performance would decline.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars